Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that Ken Horne, Chief Executive Officer, will present an overview of the company pipeline at the BioCentury 25th Annual Future Leaders in the Biotech Industry Conference in New York.
March 15, 2018
· 1 min read